Literature DB >> 12097800

Matrix metalloproteinases and their inhibitors in exfoliation syndrome.

S P Gartaganis1, C D Georgakopoulos, E K Mela, A Exarchou, N Ziouti, M Assouti, D H Vynios.   

Abstract

The purpose of this study was to determine the expression of metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the aqueous humour of patients with exfoliation syndrome (XFS). XFS and control samples were analysed for their MMP content by zymography and for their tissue inhibitors by ELISA. In XFS eyes, an increase for up to 60% in almost all MMPs was observed, as compared to the controls. MMP-2 and MMP-9 were found to predominate. TIMP-1 levels in XFS samples were slightly decreased, while TIMP-2 levels were similar to those of the controls. Our findings suggest that MMPs may be crucial in the progression of XFS, by degrading the abnormal fibrillar matrix components in the anterior segment tissues of XFS eyes. However, the increased levels of MMPs seem not to be able to overcome the overproduction and accumulation of the exfoliative material. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097800     DOI: 10.1159/000063661

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  10 in total

1.  Pseudoexfoliation as a risk factor for peripheral vascular disease: a case-control study.

Authors:  M R Praveen; S K Shah; A R Vasavada; R P Diwan; S M Shah; B R Zumkhawala; R Thomas
Journal:  Eye (Lond)       Date:  2010-12-03       Impact factor: 3.775

2.  Serum prolidase activity and oxidative stress in patients with pseudoexfoliation syndrome.

Authors:  Mehmet Tetikoğlu; Haci Murat Sağdik; Serdar Aktas; Fatma Uçar; Fatih Özcura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-15       Impact factor: 3.117

3.  Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome.

Authors:  S L Ho; G F Dogar; J Wang; J Crean; Q D Wu; N Oliver; S Weitz; A Murray; P E Cleary; C O'Brien
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

Review 4.  Pseudoexfoliation syndrome and cardiovascular diseases.

Authors:  Georgios K Andrikopoulos; Dimitrios K Alexopoulos; Sotirios P Gartaganis
Journal:  World J Cardiol       Date:  2014-08-26

5.  Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome.

Authors:  G G Koliakos; A G P Konstas; U Schlötzer-Schrehardt; G Hollo; D Mitova; D Kovatchev; S Maloutas; N Georgiadis
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

6.  Evaluation of MMP1 and MMP3 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.

Authors:  Evangelia E Tsironi; Maria Pefkianaki; Aspasia Tsezou; Maria G Kotoula; Efthimios Dardiotis; Pavlina Almpanidou; Afroditi A Papathanasiou; Paraskevi Rodopoulou; Dimitrios Z Chatzoulis; Georgios M Hadjigeorgiou
Journal:  Mol Vis       Date:  2009-12-25       Impact factor: 2.367

7.  Novel Data about Association of the Functionally Significant Polymorphisms of the MMP9 Gene with Exfoliation Glaucoma in the Caucasian Population of Central Russia.

Authors:  Dina Starikova; Irina Ponomarenko; Evgeny Reshetnikov; Volodymyr Dvornyk; Mikhail Churnosov
Journal:  Ophthalmic Res       Date:  2020-10-23       Impact factor: 2.892

8.  Statistical analysis of pseudoexfoliation syndrome prevalence, glaucoma and coronary artery disease of the patients with cataract.

Authors:  Yong Xu; Nicolaos Cosmas; Sotirios Gartaganis
Journal:  Int J Biomed Sci       Date:  2011-03

Review 9.  Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations.

Authors:  Eman Elhawy; Gautam Kamthan; Cecilia Q Dong; John Danias
Journal:  Hum Genomics       Date:  2012-10-10       Impact factor: 4.639

10.  Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforming growth factor beta 1 in the aqueous humor and serum of patients with pseudoexfoliation syndrome.

Authors:  Selcuk Kara; Nilgun Yildirim; Ahmet Ozer; Omer Colak; Afsun Sahin
Journal:  Clin Ophthalmol       Date:  2014-01-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.